Skip to main content
Have a personal or library account? Click to login
Adverse Health Effects Of Indoor Moulds / Štetni Zdravstveni Učinci Plijesni Unutarnjih Prostora Cover

Adverse Health Effects Of Indoor Moulds / Štetni Zdravstveni Učinci Plijesni Unutarnjih Prostora

By:   
Open Access
|Jan 2013

References

  1. 1. Kroling P. [Sick Building Syndrom. Symptome, Ursachen, und Prophylaxe gebaudebedingter Gesundheitsstorungen, in German].Allergologie 1998;21:180-91.
  2. 2. Burge PS. Sick building syndrome. Occup Environ Med 2004;61:185-90.
  3. 3. Yang G-H, Jarvis, BB, Chung Y-J, Pestka JJ. Apoptosis induction by satratoxins and other trichothecene mycotoxins: Relatinship to ERK, p38 MAPK, and SAPK/JNK activation. Toxicol Appl Pharmacol 2000;164:149-60.
  4. 4. Jaakkola MS, Piipari R, Jaakkola JJK. Occupation and asthma: A populatin-based incident case-control study. Am J Epidemiol 2003;158:981-7.
  5. 5. Crook B, Burton NC. Indoor moulds, sick building syndrome and building related illness. Fungal Biol Rev 2010;24:106-13.
  6. 6. Pieckova E, Wilkins K. Airway toxicity of house dust and its fungal composition. Ann Agric Environ Med 2004;11:67-73.
  7. 7. Pieckova E, Jesenska Z. Študium mykotickej kontaminacie omietok[Evaluation offungal contamination of plasters, in Slovak]. Hygiena 2000;45:37-41.
  8. 8. Pieckova E, Pivovarova Z, Sternova Z, Droba E. Building materials vs. fungal colonization - model experiments. In: Brebbia CA, editor. Environmental Health Risk IV. Southampton: WitPress; 2007. p. 71-8.
  9. 9. Garrett MH, Rayment PR, Hooper MA, Abramson MJ, Hooper BM. Indoor airborne fungal spores, house dampness and associations with environmental factors and respiratory health in children. Clin Exp Allergy 1998;28:459-67.
  10. 10. Hendry KM, Cole EC. A review of mycotoxins in indoor air. J Toxicol Environ Health 1993;38:161-82.
  11. 11. Larsen FO, Clementsen P, Hansen M, Maltbaek N, Ostenfeldt- Larsen T, Nielsen KF, Gravesen S, Skov PS, Norn S. Volatile organic compounds from the indoor mouldcause histamine release from human bronchoalveolar cells. Inflamm Res 1998;47(Suppl 1):S5-6.
  12. 12. Korpi A, Pasanen A-L, Pasanen P, Kalliokoski P. Microbial growth and metabolism in house dust. Int Biodeterior Biodegrad 1997;40:19-27.
  13. 13. Perry LP, Iwata M, Tazelaar HD, Colby TV, Yousem SA. Pulmonary mycotoxicosis: A clinicopathologic study of three cases. Mod Pathol 1998;11: 432-6.
  14. 14. Kuhn DM, Ghannoum MA. Indoor mold, toxigenic fungi, andInfectious disease perspective. Clin Microbiol Rev 2003;16:144-72.
  15. 15. Andersen B, Nielsen KF, Jarvis B. Characterisation of morphologically, chemically and physiologically differentspecies from water-damaged buildings. Mycologia 2002;94:392-403.
  16. 16. Hintikka E-L. The role ofin the phnomenon known as sick building syndrome. In: Straus DC, editor. Advances in applied microbiology. Vol 55. San Diego: Elsevier Academic Press; 2004. p. 155-73.
  17. 17. Nielsen KF, Hansen MO, Larsen TO, Thrane U. Production of trichothecene mycotoxins on water damaged gypsum boards in Danish buildings. Int Biodeterior Biodegrad 1998;42:1-7.
  18. 18. Pieckova E, Hurbankova M, Černa S, Pivovarova Z, Kovačikova Z. Pulmonary cytotoxicity of secondary metabolites of(Ehrenb.) Hughes. Ann Agric Environ Med 2006;13:259-62.
  19. 19. Pieckova E, Hurbankova M, Černa S, Liškova A, Kovačikova Z, Kollarikova Z, Wimmerova S. Inflammatory and haematotoxic potential of indoor(Ehrenb.) Hughes metabolites. Arh Hig Rada Toksikol 2009;60:401-9.
  20. 20. Rao CY, Burge HA, Brain JD. The time course of responses to intratracheally instilled toxicspores in rats. Mycopathologia 2000;149:27-34.
  21. 21. Ren P, Ahearn DG, Crow Jr SA. Mycotoxins ofproduced on celing tiles. J Ind Microbiol Biotechnol 1998;20:53-4.
  22. 22. Gravesen S, Frisvad JC, Samson RA. Microfungi. Copenhagen: Munksgaard; 1994.
  23. 23. Nielsen KF, Thrane U, Larsen TO et al. Production of mycotoxins on artificially inoculated building materials. Int Biodeter Biodegrad 1998;42:9-16.
  24. 24. Gravesen S, Nielsen PA, Iversen R, Nielsen KF. Microfungal contamination of damp buildings - examples of risk constructions and risk materials. Environ. Health Perspect 1999;107(Suppl 3):505-8.
  25. 25. Wilkins K, Pieckova E. Detection of ciliostatic activity in fungal growth on building materials. Environ Sci Pollut Res 2002;9:105-6.
  26. 26. Jesenska Z, Bernat D. Efects of mycotoxins onmovement of tracheal cilia from one-day-old chicks. Folia Microbiol 1994;39:155-8.
  27. 27. Pieckova E.toxicity of indoorKunze ex Fr. Ann Agric Environ Med 2003;10:9-14.
  28. 28. Pieckova E, Kunova Z. Indoor fungi and their ciliostatic metabolites. Ann Agric Environ Med 2002;9:59-63.
  29. 29. Nikulin M, Reijula K, Jarvis BB, Hintikka E-L. Experimental lung mycotoxicosis in mice induced by. Int J Exp Pathol 1996;77:213-8.
  30. 30. Nikulin M, Reijula K, Jarvis BB, Veijalainen P, Hintikka EL. Effects of intranasal exposure to spores ofin mice. Fundam Appl Toxicol 1997;35:182-8.
  31. 31. Vesper SJ, Magnuson ML, Dearborn D, Yike I, Haugland RA. Initial characterization of the hemolysin stachylysin from. Infect Immunol 2001;69:912-6.
DOI: https://doi.org/10.2478/10004-1254-63-2012-2221 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Language: English, Croatian, Slovenian
Page range: 545 - 549
Published on: Jan 16, 2013
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services

© 2013 Elena Piecková, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons License.